Abbott Laboratories (ABT) Tops Q2 EPS by 1c; Reaffirms Outlook
Abbott Laboratories (NYSE: ABT) reported Q2 EPS of $1.23, $0.01 better ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
